Rivalry hots up for rechargeable pain devices, ANS (Advanced Neuromodulation Systems) gets US OK
This article was originally published in Clinica
Executive Summary
The FDA has given Advanced Neuromodulation Systems (ANS) the all-clear to join the emerging US market for implantable spinal cord stimulation systems that are rechargeable.